USFDA nod to Pfizer, Astellas Pharma Xtandi for early prostate cancar Ruchika Sharma17 Nov 2023 12:30 PM ISTTokyo: Pfizer Inc. and Astellas Pharma Inc. have announced that the companies have received approval from the U.S. Food and Drug Administration...
Pfizer hair loss drug Litfulo approved in UK Ruchika Sharma2 Nov 2023 11:30 AM ISTAlopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps.
Q2 results: Pfizer reports 52.11 percent decline in net profit at Rs 148.96 crore Ruchika Sharma31 Oct 2023 3:30 PM ISTNew Delhi: Drug firm Pfizer Ltd has reported 52.11 per cent decline in net profit at Rs 148.96 crore for the second quarter ended September 2023.The...
Pfizer gains unconditional EU antitrust nod for proposed USD 43 billion Seagen acquisition Ruchika Sharma22 Oct 2023 12:30 PM IST"The proposed merger would not raise competition concerns," the EU antitrust watchdog said in a statement.
USFDA nod for Pfizer Meningococcal vaccine Penbraya Ruchika Sharma21 Oct 2023 12:30 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved PENBRAYA (meningococcal groups A, B, C, W and Y...
EU medicines regulator recommends conditional marketing nod for Pfizer blood cancer therapy Ruchika Sharma15 Oct 2023 2:15 PM ISTNew York: The European Union medicines regulator has recommended a conditional marketing authorization for U.S. drugmaker Pfizer's therapy for a type...
Pfizer slashes full-year revenue forecast by 13 percent on lower COVID sales Ruchika Sharma15 Oct 2023 11:30 AM ISTNew York: Pfizer has slashed its full-year revenue forecast by 13% and said it will cut $3.5 billion worth of jobs and expenses due to...
USFDA approves Pfizer Velsipity for adults with Ulcerative Colitis Ruchika Sharma14 Oct 2023 2:30 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved VELSIPITY (etrasimod), an oral, once-daily,...
Pfizer gets USFDA nod for Braftovi plus Mektovi for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer Ruchika Sharma14 Oct 2023 10:30 AM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) + MEKTOVI (binimetinib)...
Pfizer-BioNTech resolves Promosome patent lawsuit over COVID vaccine Ruchika Sharma7 Oct 2023 12:30 PM ISTPfizer and BioNTech denied the allegations and claimed Promosome had withheld information from the U.S. Patent Office when applying for the patent...
AstraZeneca rare disease unit acquires Pfizer portfolio for USD 1 billion Ruchika Sharma22 Sept 2023 2:25 PM ISTAstraZeneca's Rare-Disease Unit
Pfizer Litfulo gets European Commission approval for adolescents, adults with severe alopecia areata Ruchika Sharma21 Sept 2023 3:30 PM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for LITFULO (ritlecitinib) to treat...
